Blog

Proof in Publications – The Most Cited. The Most Trusted. TriNetX Real-World Data.

Thursday, Oct 09

Written by TriNetX

Explore. Discover. Connect.

Download the Infographic

The Most Cited. The Most Trusted. TriNetX Real-World Data

Leading the Way.

TriNetX is the most cited EHR dataset in peer-reviewed publications.

  • Cited more often, by more researchers, than our top competitors
  • Outpacing the field by a wide margin
  • The clear choice researchers trust to power their real-world evidence (RWE) generation

 

Total Citations (2018-2025): TriNetX vs Top 5 Competitors

PubMed data as of August 27, 2025.

Citations on the Rise. Trust on the Rise.

Global researchers choose TriNetX (and the numbers prove it).

  • Citations accelerating year over year
  • Evidence of sustained adoption and growing trust
  • Proof that TriNetX fuels high-impact science

 

TriNetX Publication Results by Year

PubMed data as of August 27, 2025.

Published Where It Matters Most.

J ALLERGY CLIN IMMUNOL
VOLUME 155, NUMBER 2

Treatment Patterns in Idiopathic Hypereosinophilic Syndrome (I-HES) or Lymphocytic HES (L-HES) in The United States: A Real-World Retrospective Observational Cohort Study

Pongdee, Thanai et al. (2025). Treatment Patterns in Idiopathic Hypereosinophilic Syndrome (I-HES) or Lymphocytic HES (L-HES) in The United States: A Real-World Retrospective Observational Cohort Study. Journal of Allergy and Clinical Immunology, Volume 155, Issue 2, AB83.

Prestige.

Research utilizing TriNetX real-world data (RWD) appears in the world’s top journals.

JAMIA OPEN
VOLUME 7, ISSUE 3

Leveraging a global, federated, real-world data network to optimize investigator-initiated pediatric clinical trials: the TriNetX Pediatric Collaboratory Network

Jurran L Wilson, Marisol Betensky, Sharda Udassi, Pavithra R Ellison, Richard Lilienthal, Lindsay R Stahl, Matvey B Palchuk, Ayesha Zia, Deborah A Town, Wes Kimble, Neil A Goldenberg, Hiroki Morizono, Leveraging a global, federated, real-world data network to optimize investigator-initiated pediatric clinical trials: the TriNetX Pediatric Collaboratory Network, JAMIA Open, Volume 7, Issue 3, October 2024, ooae077

Impact.

Studies shaping the future of medicine.

NATURE MEDICINE
VOLUME 30, 2777–2781

The recombinant shingles vaccine is associated with lower risk of dementia

Taquet, M., Dercon, Q., Todd, J.A., et al. (2024). The recombinant shingles vaccine is associated with lower risk of dementia. Nature Medicine, 30, 2777–2781.

Influence.

Setting the gold standard in peer-reviewed science.

Behind Every Citation is the Power of TriNetX RWD.

Worldwide. Secure. Fit for Purpose.

  • Secure, onsite data capture behind each healthcare organization’s firewall
  • Instant access to query and mine rich longitudinal clinical data
  • Diagnoses, labs, vitals, BMI, medications, procedures, race and ethnicity, and social determinants of health
  • Advanced analytics that turn complex questions into actionable RWE

 

Why do more researchers cite TriNetX?
Because more researchers trust TriNetX.

TriNetX leads in publications because it leads in scale, diversity, and data quality.

 

  • Unmatched Data
  • Proven Credibility
  • Consistent Impact

Don’t just publish. Advance science.

Join the researchers driving tomorrow’s breakthroughs. Contact us today.
Contact us